Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
PROK similar filings
- 8 Sep 22 Regulation FD Disclosure
- 12 Aug 22 Prokidney’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
- 11 Aug 22 ProKidney Corp. Reports Second Quarter 2022 Financial Results and Provides Business Update
- 15 Jul 22 Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
- 12 Jul 22 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 8 Jul 22 Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General
- 6 Jul 22 Other Events
Filing view
External links
Exhibit 16.1
July 15, 2022
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read the statements made by ProKidney Corp. under Item 4.01 of its Form 8-K dated July 15, 2022. We agree with the statements concerning our Firm under Item 4.01. We are not in a position to agree or disagree with other statements contained therein.
Very truly yours,
/s/ MarcumLLP
MarcumLLP
New York, NY